+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type (Surgical Clipping, Endovascular Coiling), By End-use (Hospitals, Clinics), By Region (Asia Pacific, North America, Europe), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899527

Quick Summary:

In the continuously evolving world of healthcare, understanding the market trends and growth opportunities in the field of intracranial aneurysm management is essential for strategic decision making. As the number of individuals battling intracranial aneurysms continues to increase, so does the demand for effective therapeutic solutions. Our comprehensive market research report gives you an in-depth look at this emerging market, providing insights into key trends, growth drivers, and potential opportunities.

Get ahead of your competitors and unlock business potential by delving into analysis on the growing demand for intracranial aneurysm products and cutting-edge technologies. Our report also explores the impact of various factors influencing market expansion, including an aging population, increasing global incidences of cerebrovascular disorders, and continuous product launches by industry leaders. Furthermore, it offers a detailed view of the impressive strides being made in developing regions thanks to increased disposable incomes and improved healthcare accessibility. Don't be left behind; secure your copy of this insightful research report today.

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights

  • In 2022, the endovascular coiling segment dominated the market with a share of 84.82%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas
  • The hospitals end-use segment held the largest revenue share of 89.52% in 2022. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals
  • North America dominated the market with a share of 26.91% in 2022. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships
  • Thus, the presence of key players in North America is expected to boost the regional market growth


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Intracranial Aneurysm Market

What is the estimated value of the Global Intracranial Aneurysm Market?

The Global Intracranial Aneurysm Market was estimated to be valued at $1.17 Billion in 2022.

What is the growth rate of the Global Intracranial Aneurysm Market?

The growth rate of the Global Intracranial Aneurysm Market is 9.0%, with an estimated value of $2.33 Billion by 2030.

What is the forecasted size of the Global Intracranial Aneurysm Market?

The Global Intracranial Aneurysm Market is estimated to be worth $2.33 Billion by 2030.

Who are the key companies in the Global Intracranial Aneurysm Market?

Key companies in the Global Intracranial Aneurysm Market include Medtronic, Stryker, MicroPort Scientific Corporation., Johnson & Johnson Services, Inc., MicroVention Inc., B. Braun Melsungen AG and Integra LifeSciences.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Intracranial Aneurysm Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurological diseases
3.4.1.2. Technological advancements
3.4.1.3. Increasing preferance for targeted therapy approach
3.4.2. Market restraint analysis
3.4.2.1. Risk of DBS surgery
3.4.2.2. Complex regulatory framework
3.5. Intracranial Aneurysm Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Intracranial Aneurysm Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Surgical Clipping
4.1.2. Endovascular Coiling
4.1.3. Flow Diverters
4.1.4. Others
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Intracranial Aneurysm Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Surgical Clipping
4.5.1.1. Surgical clipping market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Endovascular Coiling
4.5.2.1. Endovascular coiling market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Flow Diverters
4.5.3.1. Flow diverters market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Intracranial Aneurysm Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Clinics
5.1.3. Others
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Intracranial Aneurysm Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Clinics
5.5.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Intracranial Aneurysm Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 - 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 - 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 - 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Type benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Stryker
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Type benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MicroPort Scientific Corporation.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Type benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Johnson & Johnson Services, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Type benchmarking
7.3.7.4. Strategic initiatives
7.3.8. MicroVention Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Type benchmarking
7.3.8.4. Strategic initiatives
7.3.9. B. Braun Melsungen AG
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Type benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Integra LifeSciences
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Type benchmarking
7.3.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global intracranial aneurysm market, by region 2018-2030 (USD Million)
Table 4 Global intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 5 Global intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 6 North America intracranial aneurysm market, by country, 2018-2030 (USD Million)
Table 7 North America intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 8 North America intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 9 U.S. intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 10 U.S. intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 11 Canada intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 12 Canada intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 13 Europe intracranial aneurysm market, by country, 2018-2030 (USD Million)
Table 14 Europe intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 15 Europe intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 16 UK intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 17 UK intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 18 Germany intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 19 Germany intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 20 France intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 21 France intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 22 Italy intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 23 Italy intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 24 Spain intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 25 Spain intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 26 Denmark intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 27 Denmark intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 28 Sweden intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 29 Sweden intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 30 Norway intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 31 Norway intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 32 Asia Pacific intracranial aneurysm market, by country, 2018-2030 (USD Million)
Table 33 Asia Pacific intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 34 Asia Pacific intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 35 Japan intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 36 Japan intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 37 China intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 38 China intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 39 India intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 40 India intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 41 Australia intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 42 Australia intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 43 Thailand intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 44 Thailand intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 45 South Korea intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 46 South Korea intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 47 Latin America intracranial aneurysm market, by country, 2018-2030 (USD Million)
Table 48 Latin America intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 49 Latin America intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 50 Brazil intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 51 Brazil intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 52 Mexico intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 53 Mexico intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 54 Argentina intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 55 Argentina intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 56 MEA intracranial aneurysm market, by country, 2018-2030 (USD Million)
Table 57 MEA intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 58 MEA intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 59 South Africa intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 60 South Africa intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 61 Saudi Arabia intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 62 Saudi Arabia intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 63 UAE intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 64 UAE intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
Table 65 Kuwait intracranial aneurysm market, by type, 2018-2030 (USD Million)
Table 66 Kuwait intracranial aneurysm market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Intracranial aneurysm market: Market snapshot
Fig. 9 Intracranial aneurysm market: Market segmentation
Fig. 10 Intracranial aneurysm market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Intracranial aneurysm market driver impact
Fig. 14 Intracranial aneurysm market restraint impact
Fig. 15 Intracranial aneurysm market porter’s five forces analysis
Fig. 16 Intracranial aneurysm market PESTEL analysis
Fig. 17 Intracranial aneurysm market segment dashboard
Fig. 18 Intracranial aneurysm market: Type movement Analysis
Fig. 19 Surgical clipping market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Endovascular coiling market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Flow diverters market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Intracranial aneurysm market: End-use movement Analysis
Fig. 24 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 Clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Global Intracranial aneurysm market: Regional movement analysis
Fig. 28 Global Intracranial aneurysm market: Regional outlook and key takeaways
Fig. 29 Global market share, by region
Fig. 30 North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 36 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 37 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 China market estimates and forecast, 2018-2030 (USD Million)
Fig. 45 India market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 47 Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 49 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 51 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Middle East and Africa. market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 57 Kuwait market estimates and forecast, 2018-2030 (USD Million)

Companies Mentioned

  • Medtronic
  • Stryker
  • MicroPort Scientific Corporation.
  • Johnson & Johnson Services, Inc.
  • MicroVention Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences

Methodology

Loading
LOADING...